The post Stimulated Raman histology first appeared on Lightcore Technologies.

Today, cancer diagnosis relies on complex techniques that are not always suited to emergency situations, such as surgery. At Lightcore Technologies, we’ve developed an innovative solution that could change all that.

Imagine a tool that enables doctors to see tissue structures at the cellular level, almost in real time. That’s what we’ve created with the BondXplorer™ microscope. Our technology, based on stimulated Raman imaging, can detect cancer in untreated human surgical specimens. It generates histological images that resemble those obtained with current techniques, but much more rapidly.

Our DC-SRS microscope uses this technology to follow the evolution of tumors in tissue. It produces images almost identical to those obtained with conventional techniques, but 100 times faster. This means that doctors could have access to crucial cancer information during surgery, without having to wait for test results.

We have already tested our technology on the brain and gastrointestinal system, and the results are promising. We believe it has the potential to revolutionize medical imaging in many fields.

If you would like to find out more about our revolutionary technology, please contact our PR team.

You can also see our BondXplorer technology in action on our YouTube channel:

The post BondXplorer™ multimodal microscope first appeared on Lightcore Technologies.

Lightcore Technologies, an innovative company in the field of non-linear optical imaging, offers new hope for research into neurodegenerative diseases and cancer. Thanks to our InSplorer™ technology, we enable in-vivo brain imaging in freely-moving rodents, opening up new avenues for studying neuronal responses in their natural context.

Visualizing neurons in vivo: a world first

Lightcore Technologies InSplorer™ is the first commercial system to enable the visualization of neurons in-vivo. This major advance offers researchers an unprecedented window onto brain function, enabling them to study neuronal responses in their natural context. This could lead to revolutionary discoveries in the understanding and treatment of neurodegenerative diseases.

Concept validation by the Institut de la Méditerranée

The InSplorer™ concept has been validated by the Institut de Neurobiologie de la Méditerranée (INMED ), a renowned institution in the field of medical research. This validation underlines the potential of InSplorer™ technology and reinforces its credibility in the scientific community.

A revolution in cancer diagnosis

But the InSplorer™ is not limited to the study of neurodegenerative diseases. It also has the potential to revolutionize cancer diagnosis. Indeed, the InSplorer™ enables in-vivo diagnosis without the use of fluorescent markers, which could be a game-changer in the early detection of cancer.

In conclusion, Lightcore Technologies is at the forefront of innovation in medical imaging. Thanks to our InSplorer™ technology, they offer new hope for research into neurodegenerative diseases and cancer. For more information, please contact our team.

The post InSplorer™ flexible endoscope first appeared on Lightcore Technologies.

Lightcore Technologies is an innovative company that paves the way in the field of nonlinear optical imaging. Our cutting-edge technologies offer unprecedented potential for advancing research into neurodegenerative diseases, cancer and many other biomedical and scientific fields. Founded by photonics experts and backed by leading academic institutions, our mission is to transform medical research and patient care through our state-of-the-art imaging technologies.

Our products: BondXplorer Microscope and InSplorer Endoscope

Our commitment: Innovation and collaboration

New hope for neurodegenerative diseases

Our InSplorer™ technology offers enormous potential for advancing research into neurodegenerative diseases. By enabling in-vivo brain imaging in freely-moving rodents, we are opening up new avenues for studying neuronal responses in their natural context. This could lead to revolutionary discoveries in the understanding and treatment of neurodegenerative diseases.

The InSplorer™ is the fruit of our commitment to innovation and is based on a unique patented technology. It offers high spatial resolution and enhanced sensitivity, making it ideal for studying neurodegenerative diseases. What’s more, its ease of use makes it ideally suited to the needs of researchers and clinicians alike.

A revolution in virtual histology: A new hope for rapid cancer diagnosis

Conventional hematoxylin, eosin and saffron (HES) histopathology, currently the “gold standard” for the pathological diagnosis of cancer, requires complex sample preparations that are not compatible with intraoperative situations where rapid decisions need to be made. Lightcore Technologies offers a solution to this challenge, providing pathologists with a near real-time technology that reveals tissue structures at the cellular level with HES histological quality. This tool could prove precious in guiding surgery, offering clear clinical benefit.

We have developed an innovative technology based on stimulated Raman imaging, capable of detecting cancer on untreated human surgical specimens. This technology, called Stimulated Raman Histology (SRH), generates images that mimic conventional HES histopathological staining, combining chemical and collagen information.

Our DC-SRS BondXplorer™ microscope uses this technology to detect tumor progression in tissue. It acquires images in the CH₂ (2850 cm-1) and CH₃ (2950 cm-1) bands, producing images virtually identical to those obtained in conventional histology, but in 100 times less time. This breakthrough paves the way for instantaneous label-free histology in an intraoperative setting.

Our technology is applicable to all organs. We have already successfully tested it on the brain and the gastrointestinal system, demonstrating its potential to revolutionize medical imaging in many fields.

These advances represent a revolution in histology and neurology, offering enormous potential for the rapid diagnosis of cancer. We invite you to come and see for yourself the revolutionary potential of our technologies. For further information, please contact our PR team.

For more information on the BondXplorer™ technology :

The post Revolutionizing nonlinear imaging : a new hope for neurodegenerative disorders and cancer first appeared on Lightcore Technologies.